Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
Recruiting now · Not applicable
Conditions studied: Severe Dry Eye Syndromes, Dry Eye Syndromes
In brief
The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.
Key facts
- Study ID
- NCT06831253
- Run by
- Centre Hospitalier Universitaire de Nice
- People needed
- 20
- Starts
- 2025-03-17
- Expected to finish
- 2026-07-01
- Last updated by the study team
- 2025-03-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Platelet counts, and clotting factors in the standarts
- Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist
You may not qualify if…
- Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
- Patients with complete stenosis of both lacrimal meatus in the treated eye
Where it is running
- CHU de Nice — Nice, Site Principal Investigator, France (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.